NEXGEL, INC. Other Nonoperating Income (Expense)
NEXGEL, INC. (NXGL) reported Other Nonoperating Income (Expense) of -$1.02 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2022-05-13
- NEXGEL, INC. other nonoperating income (expense) for the quarter ending 2022-03-31 was -$1.02M.
- NEXGEL, INC. other nonoperating income (expense) for the quarter ending 2021-12-31 was -$752.00K.
- NEXGEL, INC. other nonoperating income (expense) for the quarter ending 2021-09-30 was -$532.00K.
- NEXGEL, INC. other nonoperating income (expense) for the quarter ending 2021-06-30 was -$273.00K, a 2830.00% decline year-over-year.
- NEXGEL, INC. other nonoperating income (expense) for fiscal 2021 was -$1.74M.
- NEXGEL, INC. other nonoperating income (expense) for fiscal 2020 was -$4.00K, a 500.00% decline from fiscal 2019.
- NEXGEL, INC. other nonoperating income (expense) for fiscal 2019 was $1.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$1.02M 10-Q · filed 2022-05-13 | -$1.78M derived: sum of 2 quarters · filed 2022-05-13 | -$2.31M derived: sum of 3 quarters · filed 2022-05-13 | -$2.58M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | -$752.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$1.28M derived: sum of 2 quarters · filed 2022-03-21 | -$1.56M derived: sum of 3 quarters · filed 2022-03-21 | -$1.74M 10-K · filed 2022-03-21 |
| 2021-09-30 | -$532.00K 10-Q · filed 2021-11-10 | -$805.00K derived: sum of 2 quarters · filed 2021-11-10 | -$988.00K 10-Q · filed 2021-11-10 | -$994.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | -$273.00K 10-Q · filed 2021-08-16 | -$456.00K 10-Q · filed 2021-08-16 | -$462.00K derived: sum of 3 quarters · filed 2022-05-13 | -$472.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | -$184.00K 10-Q · filed 2022-05-13 | -$189.00K derived: sum of 2 quarters · filed 2022-05-13 | -$199.00K derived: sum of 3 quarters · filed 2022-05-13 | -$189.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$15.00K derived: sum of 2 quarters · filed 2022-03-21 | -$5.00K derived: sum of 3 quarters · filed 2022-03-21 | -$4.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | -$10.00K 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $1.00K 10-Q · filed 2021-11-10 | $2.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $10.00K 10-Q · filed 2021-08-16 | $11.00K 10-Q · filed 2021-08-16 | $12.00K derived: sum of 3 quarters · filed 2021-08-16 | $12.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-17 | $2.00K derived: sum of 2 quarters · filed 2021-05-17 | $2.00K derived: sum of 3 quarters · filed 2021-05-17 | $2.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.00K derived: sum of 3 quarters · filed 2021-03-31 | $1.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |